Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation

Interchangeability, a Food and Drug Administration (FDA) designation allowing pharmacists to substitute a biosimilar for its branded originator at the point of sale, is intended to increase biosimilar adoption. However, little is known about the relationship between interchangeability and biosimilar...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Health affairs (Millwood, Va.) Jg. 44; H. 11; S. 1417
Hauptverfasser:	Kakani, Pragya, Katcher, Bradley A, Maini, Luca
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.11.2025
Schlagworte:	Biosimilar Pharmaceuticals - economics Biosimilar Pharmaceuticals - therapeutic use Health Benefit Plans, Employee - statistics & numerical data Humans Insurance Coverage - statistics & numerical data Interrupted Time Series Analysis Medicaid - statistics & numerical data United States United States Food and Drug Administration United States
ISSN:	2694-233X, 2694-233X
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!